Physician profile
Colin S Beach
NPI 1790737898
$2,455.65
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $737 · 2020: $549 · 2021: $737 · 2022: $433.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.73 | 2021-2022 | |
| Novo Nordisk INC | $390.41 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $256.72 | 2019-2021 | |
| Lilly USA, LLC | $183.03 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $138.58 | 2019-2022 | |
| Pfizer INC. | $129.09 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.99 | 2021-2022 | |
| Eisai INC. | $109.21 | 2020-2021 | |
| Amarin Pharma, INC. | $84.45 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.64 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $55.53 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $47.91 | 2019 | |
| Allergan, INC. | $40.14 | 2019-2020 | |
| Aytu Biopharma, INC. | $37.86 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $37.58 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $37.31 | 2019 | |
| Amgen INC. | $36.14 | 2019-2022 | |
| Therapeuticsmd, INC. | $29.27 | 2019-2020 | |
| Esperion Therapeutics, INC. | $27.88 | 2021 | |
| Abbott Laboratories | $20.42 | 2022 | |
| Lupin INC. | $18.59 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.60 | 2019 | |
| Glaxosmithkline, LLC. | $16.53 | 2019 | |
| Neos Therapeutics, LP | $16.10 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $14.84 | 2022 | |
| Dexcom, INC. | $13.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.31 | 2020 | |
| Acerus Pharmaceuticals Corporation | $13.24 | 2021 | |
| Jazz Pharmaceuticals INC. | $11.93 | 2021 | |
| Genentech USA, INC. | $11.82 | 2021 | |
| Clarus Therapeutics INC. | $7.87 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Beach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.